Ironwood Pharmaceuticals buy Wells Fargo & Company
Start price
14.12.23
/
50%
€10.20
Target price
14.12.24
€18.27
Performance (%)
-46.08%
Price
24.05.24
€5.45
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals is performing very badly with a performance of -46.08%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ironwood Pharmaceuticals | -6.034% | -6.034% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ironwood Pharmaceuticals diskutieren
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for IRWD provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Start price
Target price
Perf. (%)
€8.40
01.03.24
01.03.24
€12.91
01.03.25
01.03.25
-34.52%
24.05.24
24.05.24